Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2011-11-30
2017-10-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* African Americans/ Blacks
* Asians
* Native Hawaiians/Other Pacific Islanders
* Hispanic/Latinos
* Native Americans/Alaskan Natives
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)
NCT00593983
Financial Incentives, Randomization With Stepped Treatment Trial
NCT03089320
Improving the Organizational Social Context to Address Structural Racism and Discrimination
NCT06462807
Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens
NCT02291224
Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents
NCT00640653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our specific approach is directed toward multi-site trials conducted at specialty clinics within academic centers with recruiting venues that include community practices or practices of colleagues in other areas of the academic center. The intervention will focus on approximately 60 specialty clinics. Clinical sites will be randomized to the intervention or control group. The target of the intervention will be the site investigators and clinical trial coordinators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RECRUIT intervention
Clinical sites will work with the RECRUIT team to enhance and individualize their recruitment methods.
RECRUIT intervention
Sites randomized to RECRUIT are taught skills to develop a tailored recruitment intervention encompassing continuous quality improvement and patient navigation.
Control
Clinical sites can use which ever recruitment methods they prefer.
Control
Non-intervention control.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RECRUIT intervention
Sites randomized to RECRUIT are taught skills to develop a tailored recruitment intervention encompassing continuous quality improvement and patient navigation.
Control
Non-intervention control.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have a coordinating Center willing to allow their Clinical Sites to participate;
* be studying be studying a condition that requires community or health system physician referral
* be studying an intervention where the recruitment approach cannot be made directly to minority community members
* need to increase recruitment of racially/ethnically diverse participants\* to the trial as demonstrated by current trial progress or historical data from other trials in the same disease;
* be a Phase II or Phase III trial
* be conducted in at least six multiple sites;
* expect each Clinical Site to recruit at least 10 participants;
* be funded by a sponsor (NIH or pharmaceutical company or other) that has a strong commitment to recruiting racially/ethnically diverse subjects;
* be willing to have investigators and coordinators attend a special training meeting (at RECRUIT expense);
* require randomization to intervention or control (could be best medical care or active control or placebo or other type of control);
* provide transportation costs for trial participants who need assistance in getting to trial sites or use some RECRUIT reimbursement for this purpose.
The clinical site must
* be a funded Clinical Site in the parent trial;
* be located in an area where at least 20% of the population within 30 miles in the age group under study in the parent trial are from diverse populations.
Exclusion Criteria
* investigator or coordinator is under 18 years of age.
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbara Tilley
SPH Faculty - Biostatistics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara C. Tilley, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas Health Science Center School of Public Health
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tilley BC, Mainous AG 3rd, Amorrortu RP, McKee MD, Smith DW, Li R, DeSantis SM, Vernon SW, Koch G, Ford ME, Diaz V, Alvidrez J; additional RECRUIT Trial Center and Parent Trials' investigators. Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial. Contemp Clin Trials. 2021 Oct;109:106519. doi: 10.1016/j.cct.2021.106519. Epub 2021 Jul 30.
DeSantis SM, Li R, Zhang Y, Wang X, Vernon SW, Tilley BC, Koch G. Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions. Clin Trials. 2020 Dec;17(6):627-636. doi: 10.1177/1740774520936668. Epub 2020 Aug 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIMHD006941
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.